865 PheT/TilS domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Lipids and lipid-like molecules | 1 | 0.4 | 2.28× | not tested | |
| Organic acids and derivatives | 1 | 0.6 | 1.64× | not tested | |
| Organic oxygen compounds | 1 | 0.8 | 1.27× | not tested | |
| Homogeneous non-metal compounds | 1 | 0.9 | 1.18× | not tested | |
| Nucleosides, nucleotides, and analogues | 1 | 1.1 | 0.92× | not tested | |
| Homogeneous metal compounds | 1 | 1.9 | 0.52× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00135 | TYR | Tyrosine | 1 |
| DB02159 | PGR | (R)-Propylene glycol | 1 |
| DB02210 | HEZ | Hexane-1,6-Diol | 1 |
| DB08437 | PUY | Puromycin | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 1 |
| DAH | 3,4-DIHYDROXYPHENYLALANINE | 1 |
| HEZ | HEXANE-1,6-DIOL | 1 |
| Kmetal | POTASSIUM ION | 1 |
| MGmetal | MAGNESIUM ION | 1 |
| MTY | META-TYROSINE | 1 |
| PGR | R-1,2-PROPANEDIOL | 1 |
| PUY | PUROMYCIN | 1 |
| TYR | TYROSINE | 1 |